WellAhead Podcasts
Beyond healthy lifestyle choices, medications are often the most cost-effective, least-invasive treatment available to maintain health and postpone illness. In the complex business of pharmacy benefits, converging forces are shaping the future – from technology to patient-provider relationships to the drug pipeline crowded with biosimilars. WellAhead Podcasts feature some of the industry’s best-known thought leaders who guide you through current topics to inform and clarify key areas impacting patient care – and the plan’s bottom line. WellDyne consistently receives national recognition for care management, mail service, specialty care and more, and is generous in sharing the path to standout results. Join us for episodes that reveal ideas for maximizing change and opportunity in today’s volatile pharmacy industry.
Listen on:
Episodes
Tuesday Sep 27, 2022
Tuesday Sep 27, 2022
The prospect of implementation strikes fear into the hearts of organizations contemplating a move to a new PBM, but it doesn’t have to be that way. Managed properly, implementation equals opportunity – the opportunity to innovate, add efficiencies and maximize financial results. Recognized for excellence by clients and members, the WellDyne Implementation team delivers a smooth, fast and efficient experience that brings the benefit in line with the goals of the plan. Listen in for details on how the team stands in the client’s shoes to identify and maximize every opportunity.
Monday Aug 22, 2022
Monday Aug 22, 2022
As the #1 driver of drug trend, inflammatory conditions account for 47% of all specialty pharmacy spend and 23% of overall spend. Managing this ever-growing category takes consistent effort and an arsenal of tools. In part 2 of our trend podcast, WellDyne clinical leaders Nick Page and Patty Taddei-Allen focus on inflammatory conditions to reveal how a consistent, thoughtful approach produces results. This is your opportunity to gain insight into dosing escalations, testing, diagnostics, biosimilars, and emerging opportunities and challenges in this high-cost area.
Wednesday Aug 10, 2022
Wednesday Aug 10, 2022
Drug trend isn’t something we analyze just once a year. Consistent review of client results helps us understand current challenges, deliver bold solutions and prepare for the future. A vital topic to our clients, drug trend is the PBM industry’s methodology for determining annual growth in prescription spend. In this WellAhead podcast, Nick Page, Chief Clinical and Strategy Officer, and Patty Taddei-Allen, VP, Clinical Programs and Services, share their insights into cost and utilization drivers that helped shape drug trend in 2021. This is your opportunity to preview emerging industry trends that will impact pharmacy benefits in 2022 and beyond. Stay tuned for part 2 where these WellDyne clinical leaders take a deeper look at managing specialty drug trend.